2024 - Go-To-Market Success: The Role of Capital Preservation in Life Science Research and Diagnostic Consumable Manufacturing

In this webinar, Patrick Tuohy will address a critical question encountered by most life science and diagnostic companies: Should the development and/or manufacturing of products be outsourced or in-sourced? The webinar delves into how a leading solutions provider for microfluidic devices and microarray assays can assist companies in saving capital and reducing time to market by outsourcing their development and manufacturing needs.
Business leaders in diagnostic and life science companies grapple with the challenging decision of how to produce their products. By focusing on core competencies, minimizing capital investments and embracing production flexibility, businesses can more efficiently navigate the journey from development to product launch by entering into collaborations.
In this webinar, the expert speakers will explore how life science and diagnostic companies can leverage pilot line capability. This capability consists of purpose-built manufacturing expertise within SCHOTT MINIFAB, enabling the transformation of clients’ products from initial assembled units (for feasibility testing) to the first commercial articles that contribute to improving patient health and well-being.
A common objection faced by companies is that insourcing is cheaper than outsourcing. It is crucial to understand the true costs, including those associated with capability development, facilities, equipment, administrative overhead and per capita expenses. In this webinar, the experts will thoroughly consider all relevant factors related to the development and manufacturing of products.
Register for this webinar to discover strategies for saving capital and reducing time to market in microfluidic device production and other life science consumables manufacturing.
Keywords: Microfluidic, IVD, Diagnostics, Laboratory Technology, Commercial Manufacturing, In Vitro Diagnostics, Microfluidics, Microfluidics-Based System, CDMO/CMO, Commercialization/HEOR/Market Access